AstraZeneca wants Serum Institute of India listed as manufacturing site
“We have requested the addition of Serum Institute of India as an alternative manufacturing site on the Vaxzevria licence,” an AstraZeneca spokesperson told ET. The EMA has approved AstraZenecas Vaxzevria but Covishield, which is made by SII using the same technology, hasnt got the nod.